The Florida Senate
BILL ANALYSIS AND FISCAL IMPACT STATEMENT
(This document is based on the provisions contained in the legislation as of the latest date listed below.)
Prepared By: The Professional Staff of the Committee on Rules
BILL: CS/SB 1026
INTRODUCER: Banking and Insurance Committee, and Senator Cruz
SUBJECT: Living Organ Donors in Insurance Policies
DATE: February 21, 2022
ANALYST STAFF DIRECTOR REFERENCE ACTION
1. Schrader Knudson BI FAV/CS
2. Rossitto-Van
Winkle
Brown
HP
Favorable
3. Schrader Phelps RC Favorable
Please see Section IX. for Additional Information:
COMMITTEE SUBSTITUTE - Substantial Changes
I. Summary:
CS/SB 1026 creates s. 626.97075, F.S., which revises Florida’s Unfair Insurance Trade Practices
law
1
and several parts of Florida’s Insurance Rates and Contracts law.
2
The bill makes it
unlawful to discriminate against living organ donors in specific types of insurance coverage. The
insurance types impacted by the bill are: life insurance, including industrial life insurance
3
and
group life insurance;
4
credit life insurance and credit disability insurance;
5
and long-term care
insurance.
6
1
Part IX, ch. 626, F.S.
2
Chapter 627, F.S.
3
Section 627.502, F.S. defines industrial life insurance as that form of life insurance written under policies under which
premiums are payable monthly or more often, bearing the words “industrial policy” or “weekly premium policy” or words of
similar import imprinted upon the policies as part of the descriptive matter, and issued by an insurer that, as to such industrial
life insurance, is operating under a system of collecting a debit by its agent.
4
Group life insurance is a type of life insurance policy insuring the lives of more than one individual. Pursuant to s. 627.551,
F.S., groups eligible for such coverage include employee, debtor, labor union, and trustee groups, among others.
5
Section 627.677, F.S., defines “credit life insurance” as insurance on the life of a debtor pursuant to or in connection with a
specific loan or other credit transaction and defines “credit disability insurance as: insurance under which a borrower of
money or a purchaser or a lessee of goods is insured in connection with a specific loan or credit transaction against loss of
time resulting from accident or sickness.
6
Section 627.9404, F.S., defines a “long-term care insurance policy” as an insurance policy or rider advertised, marketed,
offered, or designed to provide coverage on an expense-incurred, indemnity, prepaid, or other basis for one or more necessary
or medically necessary diagnostic, preventive, therapeutic, curing, treating, mitigating, rehabilitative, maintenance, or
personal care services provided in a setting other than an acute care unit of a hospital.
REVISED: BILL: CS/SB 1026 Page 2
The bill provides an effective date of July 1, 2022.
II. Present Situation:
The Florida Office of Insurance Regulation
The Office of Insurance Regulation (OIR) licenses and regulates the activities of life, health,
property, and casualty insurers, health maintenance organizations (HMOs), and other risk-
bearing entities. The OIR is an office within the Financial Services Commission (FSC). The FSC
is composed of the Governor, the Attorney General, the Chief Financial Officer, and the
Commissioner of Agriculture. The FSC members serve as the agency head for purposes of
rulemaking under ss. 120.536-120.565, F.S.
7
Organ Donation
Organ and tissue donation is the process of surgically removing an organ or tissue from one
person (the donor) and transplanting it into another person (the recipient) to save the life of, or
enhance the life of, the organ recipient. Transplantation is generally necessary because the
recipient’s organ has failed or has been damaged by disease or injury. Transplantable organs
include the kidneys, liver, heart, lungs, pancreas and intestine.
8
Certain tissue is also
transplantable and includes skin used as a temporary dressing for burns, serious abrasions and
other exposed areas; heart valves used to replace defective valves; tendons used to repair torn
ligaments on knees or other joints; veins used in cardiac bypass surgery; corneas used to restore
sight; and bone used in orthopedic surgery to facilitate healing of fractures or prevent
amputation.
9
A single person can save up to eight lives through organ donation, and dozens more lives may be
improved through tissue donation. Nearly 120,000 children and adults are presently awaiting
potentially life-saving organ transplants and every day 22 people die awaiting organ transplant.
10
While most organ and tissue donations occur after the donor has died, some organs and tissues
can be donated while the donor is alive, such as a kidney or part of a liver or lung.
11
There are
approximately as many living donors every year as there are deceased donors and only about
three in every 1,000 people actually become donors—despite 169 million in the United States
being registered.
12
According to United Network for Organ Sharing (UNOS), between 2017 and
2021, there were an average of 6,539 living donor transplants per year in the United States.
13
7
Section 20.121(3), F.S.
8
Donate Life Florida, Frequently Asked Questions, available at https://www.donatelifeflorida.org/categories/donation/ (last
visited Feb. 2, 2022).
9
Id.
10
Id.
11
U.S. Government Information on Organ Donation and Transplantation, U.S. Department of Health & Human Services,
How Donation Works, available at https://organdonor.gov/about/process.html (last visited Feb. 2, 2022).
12
Id.
13
UNOS, Living Donation, available at https://unos.org/transplant/living-donation/ (last visited Feb. 2, 2022). BILL: CS/SB 1026 Page 3
Organ Donation, Procurement, and Transplant Process
Established by the National Organ Transplant Act (NOTA) of 1984, the Organ Procurement and
Transplantation Network (OPTN) is a public-private partnership that links all professionals
involved in the nation’s donation and transplant system.
14
The UNOS, a private, non-profit
organization serves as the OPTN under contract with the U.S. Department of Health and Human
Services.
15
UNOS coordinates how donor organs are matched and allocated to patients on the
waiting list.
16
Non-profit, federally designated organ procurement organizations (OPOs) work
closely with UNOS, hospitals, and transplant centers to facilitate the organ donation and
transplantation process.
17
Potential Financial Impacts Relating to Organ Donation
The buying and selling of organs is unlawful under the National Organ Transplant Act of 1984.
18
However, certain organ donor expenses relating to transplant may be paid for by the recipient (or
their insurer). Generally, an organ donor and their family are not charged for the medical care
required to donate an organ.
19
Costs related to living or deceased donation are paid by the
recipient, usually through insurance.
20
Typically, any cost that falls outside of the transplant
center’s donor evaluation or actual surgery, such as travel, lodging, lost wages, and other non-
medical expenses, is borne by the living donor or recipient.
21
In addition, treatment for
conditions discovered during the evaluation portion of the donation process and some post-
donation follow-up expenses are not covered. UNOS also warns potential donors that “living
donation may have a negative impact on the ability to obtain, maintain, or afford health,
disability and life insurance.”
22
Obtaining and Affording Insurance
In 2014, the American Journal of Transplantation published a study of 1,046 donors who
underwent living kidney donation at Johns Hopkins Hospital. Of these donors, 25 percent of
those who reporting attempting to obtain new or revise life insurance policies post-procedure
reported difficulty in doing so. The difficulties reported included outright denials in obtaining
coverage, higher premiums, and the notation of a pre-existing condition relating to the kidney
donation. The same survey also noted that of the surveyed donors who reported attempting to
14
U.S. Department of Health and Human Services, Organ Procurement and Transplantation Network – About the OPTN,
available at https://optn.transplant.hrsa.gov/governance/about-the-optn/ (last visited Feb. 2, 2022).
15
Id. and About UNOS, Who we are, available at https://unos.org/about/ (last visited Feb. 2, 2022).
16
U.S. Government Information on Organ Donation and Transplantation, U.S. Department of Health & Human Services, The
Organ Transplant Process, available at https://organdonor.gov/about/process/transplant-process.html (last visited Feb. 2,
2022).
17
Donate Life Florida, Organ Procurement Organizations and Transplant Centers, available at
https://www.donatelifeflorida.org/local-resources/transplant-centers/ (last visited Feb. 2, 2022).
18
National Organ Transplant Act, 42 U.S.C. s. 274.
19
Health Resources Services Administration, Organ Donation Frequently Asked Questions, available at
https://www.organdonor.gov/learn/faq (last visited Jan. 13, 2022).
20
Id.
21
UNOS, Living Donation Costs, available at https://transplantliving.org/financing-a-transplant/living-donation-costs/ (last
visited Feb. 2, 2022).
22
Id. BILL: CS/SB 1026 Page 4
obtain new or revise health insurance policies post-procedure, 7 percent reported difficulties in
doing so.
23
Another study, also published in the American Journal of Transplantation (in 2007), which
reviewed 23 different studies over a 35-year period, concluded that a significant number of living
kidney donors do encounter difficulties in obtaining or maintaining insurance (with anywhere
between 3 to 11 percent of those surveyed reporting difficulties). That same study also found that
insurability issues caused significant stress for between 11 and 13 percent of kidney donors and
that “insurability may negatively influence one’s decision to become a living organ donor.”
24
This same study also found that these insurability issues are not isolated to kidney donors.
25
The
National Kidney Foundation also advises potential donors, in accessing the risk of donation, that
“some donors have reported difficulty in getting, affording, or keeping disability or life
insurance.”
There is some evidence that these increased difficulties and costs in obtaining life insurance is
not always based on the actual additional loss risk that organ donation presents. A 2015 study of
living kidney donors found that such donation “does not appear to increase long-term mortality
compared with controls;” however, the study did advise that it was limited in scope and more
research was needed.
26
A study of living kidney donors in Korea, published in 2019, found that,
“the risk of all-cause mortality was comparable between live kidney donors and matched non-
donor healthy controls with similar health status.”
27
A 2012 study of live liver donors found that
while 90-day mortality rates were elevated for such donors, the rates of long-term mortality were
essentially the same for live liver donors, for live kidney donors, and for healthy controls.
28
III. Effect of Proposed Changes:
CS/SB 1026 creates s. 626.97075, F.S., within Florida’s Unfair Trade Practices law (part IX of
ch. 626). The section creates a definition of “policy” as a life insurance policy, including those
for industrial life insurance and group life insurance; a credit life insurance and credit disability
insurance policy; and a long-term care insurance policy. The section specifies that an insurer
may not, in a policy, as defined by the section:
Decline or limit coverage of a person solely due to that person’s status as a living organ
donor;
23
B.J. Boyarsky, et al, Experiences Obtaining Insurance After Live Kidney Donation, 14(9) AM J TRANSPLANT. 2168-72
(2014), available at
https://www.researchgate.net/publication/263969706_Experiences_Obtaining_Insurance_After_Live_Kidney_Donation, (last
visited Feb. 2, 2022).
24
R.C. Yang, et al, Insurability of Living Organ Donors: A Systematic Review, 7(6) AM J TRANSPLANT. 1547-48 (2007),
available at https://onlinelibrary.wiley.com/doi/full/10.1111/j.1600-6143.2007.01793.x (last visited Feb. 2, 2022).
25
Id. and Nissing MH & Hayashi PH, Right hepatic lobe donation adversely affects donor life insurability up to one year
after donation, 11 LIVER TRANSPL 843–847 (2005), available at
https://aasldpubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/lt.20411 (last visited Feb. 2, 2022).
26
K.L. Lentine & A. Patel, Risks and outcomes of living donation, 19(4) ADV CHRONIC KIDNEY DIS. 220-8 (2012), available
at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4447489/ (last visited Feb. 2, 2022).
27
Y. Kim, et al, Long-term Mortality Risks Among Living Kidney Donors in Korea. 75(6) Am J Kidney Dis. 925 (2019),
available at https://www.ajkd.org/article/S0272-6386(19)31104-7/fulltext (last visited Feb. 2, 2022).
28
A.D. Muzaale, et al, Estimates of early death, acute liver failure, and long-term mortality among live liver donors, 142(2)
Gastroenterology 273-80 (2012), available at https://www.gastrojournal.org/article/S0016-5085(11)01576-9/pdf (last visited
Feb. 2, 2022). BILL: CS/SB 1026 Page 5
Preclude an insured person from donating all, or part of, an organ as a condition to
continuing to receive coverage under that person’s insurance policy; or
Otherwise discriminate in the offering, issuance, cancellation, coverage, premium, or any
other condition of a person’s policy without any additional actuarial risk, and based solely on
that person’s status as a living organ donor.
The bill also grants the FSC the authority to adopt rules and enforce these prohibitions.
Section 626.9521, F.S., specifies penalties for violations of part IX of ch. 626, F.S. A violation of
s. 626.97075, F.S., as created by the bill, would subject a person to a fine of up to $5,000 for
each nonwillful violation and up to $40,000 for each willful violation. Insurers violating the
proposed section may be fined an aggregate amount of up to $20,000 for all nonwillful violations
arising out of the same action or an aggregate amount of up to $200,000 for all willful violations
arising out of the same action. These specified fines may be imposed in addition to any specified
penalty elsewhere in law.
The bill provides an effective date of July 1, 2022.
IV. Constitutional Issues:
A. Municipality/County Mandates Restrictions:
None.
B. Public Records/Open Meetings Issues:
None.
C. Trust Funds Restrictions:
None.
D. State Tax or Fee Increases:
None.
E. Other Constitutional Issues:
None.
V. Fiscal Impact Statement:
A. Tax/Fee Issues:
None. BILL: CS/SB 1026 Page 6
B. Private Sector Impact:
Passage of this bill should have minimal fiscal impact on insurers. Given the apparent
minimal to no impact on long term mortality for the living donation of organs, the
passage of this bill should have little impact on risk carried by insurers.
C. Government Sector Impact:
None.
VI. Technical Deficiencies:
None.
VII. Related Issues:
None.
VIII. Statutes Affected:
This bill creates section 626.97075 of the Florida Statutes.
IX. Additional Information:
A. Committee Substitute – Statement of Substantial Changes:
(Summarizing differences between the Committee Substitute and the prior version of the bill.)
CS by Banking and Insurance on January 18, 2022:
The CS deletes all provisions in SB 1026 relating to health insurance; group, blanket, and
franchise health insurance; health maintenance contracts provided by health maintenance
organizations; and prepaid health contracts. The CS also deletes redundant portions of the
underlying bill which placed into individual insurance chapters the prohibitions specified
in Section 1 of the bill (which creates a new section under Florida’s Unfair Insurance
Trade Practices law).
B. Amendments:
None.
This Senate Bill Analysis does not reflect the intent or official position of the bill’s introducer or the Florida Senate.